Thursday, August 13, 2009

US FDA panel partly backs Amgen bone drug - Forexyard


US FDA panel part backs Amgen bone drug
Forexyard
Amgen shares fell 2 proportionality to $60.86 before trading winking on Nasdaq but were about modify in after-hours trading. The FDA usually approves drugs that win ...

and more »

No comments:

Post a Comment